Skip to main content
. 2020 Jan 29;12(3):207–222. doi: 10.4155/fmc-2019-0063

Table 6. . MIC, IC50 and IC90 of compounds 2b, 5, 4f, 6c and 6f against Mtb resistant at different treatment and nontuberculous mycobacteria.

Compound RIF-R2 FQ-R1 Mycobacterium abscessus
  MIC (μM) IC50 (μM) IC90 (μM) MIC (μM) IC50 (μM) IC90 (μM) MIC (μM) IC50 (μM) IC90 (μM)
2b 68 38 61 102 66 92
5 >50 >50 >50 >50 >50 >50
4f >200 40 120 87 49 91 110 89 97
6c 100 44 120 200 40 >200 >200 120 200
6f 30 17 31 38 18 38 88 56 68
C1 >50 >50 >50 0.027 0.013 0.039 3.3 2.1 3.1
C2 0.62 0.54 0.60 0.35 0.36 0.47
C3 1.1 0.60 1.2 20 12 22

Values indicate that compounds have a very good activity.

C1: Rifampicin control; C2: Isoniazid control; C3: Levofloxacin control; FQ: Fluoroquinolone resistant strain; INH: Isoniazid resistant strain; MIC: Minimum inhibitory concentration; RIF: Rifampicin resistant strain.